Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 09/21/23

Kidney SPOREs

According to the NCI's Surveillance, Epidemiology, and End Results Program (SEER) data, there will be an estimated 81,800 new cases of kidney and renal pelvis cancers and about 14,890 deaths in 2023. The average observed annual incidence rate of new cases per 100,000 persons in 2019 was 15.7, and the average annual death rate was 3.4. Kidney cancer can affect both adults and children. Metastatic kidney cancer remains largely incurable in adults. Kidney cancer in children, known as Wilms tumor, is curable in most patients, but treatment often leaves life-long sequelae. SPORE programs in kidney cancer span a wide array of projects. The SPOREs in kidney cancer foster collaborations among experts in renal cancer generating new resources and research opportunities for scientific community.